Robatumumab (IGF1R/CD221) - Research Grade Biosimilar
Product Specifications
Background
Robatumumab has been used in trials studying the treatment of Osteosarcoma, Sarcoma, Ewing's, and Peripheral Neuroectodermal Tumor.
Immunogen
Homo sapiens / IGF1R/CD221 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
19D12, SCH 717454
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC424665 20 µg
5 HT1A (HTR1A) (NM_000524) Human Over-expression Lysate
Sign In for Pricing
View Details 
KN413683 1 Kit
Cell adhesion molecULe 4 (CADM4) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC041423-100 1x 100 µL
P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/1423R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 